| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |